Classifying DLBCL Subtypes for Optimal Treatment

20:00 EDT 27 Oct 2019 | Cancer Networks

Molecular profiles allow for risk stratification Recently, ONCOLOGY discussed the classification of diffuse large B-cell lymphoma (DLBCL) into distinct subtypes and treatment decisions based on molecular classifications. We spoke with Jennifer Crombie, MD, a medical oncologist at the Dana–Farber Cancer Institute in Boston, who specializes in the care of patients with lymphoma and takes part in clinical trials of lymphoma patients.

Original Article: Classifying DLBCL Subtypes for Optimal Treatment


More From BioPortfolio on "Classifying DLBCL Subtypes for Optimal Treatment"

Quick Search

Relevant Topic

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...